1 September 2015Patents

Dow Chemical’s $30m award falls through Nautilus trapdoor

A US appeals court has reversed a decision to award $30 million in supplemental damages to The Dow Chemical Company after finding that its patents were invalid under a standard established by the US Supreme Court’s Nautilus v Biosig ruling.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

Supreme Court overturns Limelight and Nautilus cases

2 June 2014 The US Supreme Court has today overturned rulings in two patent cases that could provide guidance for future infringement lawsuits and limit the power of non-practising entities, sometimes known as “patent trolls”.

Patents

US Supreme Court agrees to hear Nautilus heart monitor case

14 January 2014 On January 10, the US Supreme Court agreed to decide on so-called ambiguous patent claims in Nautilus v Biosig Instruments.